Synthesis and Applications of 9/9,9‐Substituted Fluorene Derivatives
Advanced Synthesis & Catalysis · 23.07.2025 · 367 (13)
DOI: 10.1002/adsc.202401410 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Synthesis & Catalysis, online erschienen am 20.05.2025. Verfasst von Chao Liu und 2 weiteren Autor:innen. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 83 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Fluorene derivatives have obtained broad interest in organic synthesis, materials chemistry, and pharmaceutical fields due to their unique structure, physical, chemical and photoelectric properties. Moreover, the bare fluorene molecule has a variety of reactive sites that provides the transformations to synthesize various functionalized intermediates, polymers and macrocycles. Recently, C−C bond formation is one of useful tool in fluorene molecule modifications due to the low toxicity and high efficiency. This review covers the synthesis of various fluorene‐based small molecules, fluorene‐based polymers, fluorene‐based conjugated materials and fluorene‐based nanogrids via the C−C bond formation at the 9‐position of fluorene derivatives. Transition‐metal catalysis and metal‐free methods to synthesize different fluorene derivatives are highlighted.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liu, C., Wei, Y., & Xie, L. (2025). Synthesis and Applications of 9/9,9‐Substituted Fluorene Derivatives. Advanced Synthesis & Catalysis, 367(13). https://doi.org/10.1002/adsc.202401410
Vancouver
Liu C, Wei Y, Xie L. Synthesis and Applications of 9/9,9‐Substituted Fluorene Derivatives. Advanced Synthesis & Catalysis. 2025;367(13). doi:10.1002/adsc.202401410
BibTeX
@article{Liu2025,
author = {Liu, Chao and Wei, Ying and Xie, Linghai},
title = {Synthesis and Applications of 9/9,9‐Substituted Fluorene Derivatives},
journal = {Advanced Synthesis & Catalysis},
year = {2025},
volume = {367},
number = {13},
doi = {10.1002/adsc.202401410}
}
EUVIMED